Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $4.02-$14.06 |
Market Cap | $587.3M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $788.8M |
Revenue Growth (YoY) | -21.3% |
Gross Profit (12 Mos) | $384.3M |
Diluted EPS | $1.33 |
News
See moreYahoo Finance • 14 days ago
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
Yahoo Finance • 3 months ago
Top European Dividend Stocks For December 2025
Yahoo Finance • 4 months ago
Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge
Yahoo Finance • 4 months ago
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
About
CEO | Mr. Joseph C. Papa Jr., M.B.A., R.Ph. |
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 900 |
